Inventor
William J. McBride
Inventor
Boonton, NJ, US
Overview
Patents· 85 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
B82YSpecific uses or applications of nanostructures19%
C07KPeptides19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C12NMicroorganisms or enzymes4%
C12YEnzymes3%
C07BGeneral methods of organic chemistry2%
C07DHeterocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
9,872,920PEGylation by the dock and lock (DNL) technique20189,694,088'Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer'20179,540,618'Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses'20179,540,435'Stably tethered structures of defined compositions with multiple functions or binding specificities'20179,486,536'Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer'20169,457,100'PEGylation by the dock and lock (DNL) technique'20169,352,036'Delivery system for cytotoxic drugs by bispecific antibody pretargeting'20169,283,286'Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer'20169,169,470'Methods and compositions for generating bioactive assemblies of increased complexity and uses'20159,115,172'Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules'20159,095,628'Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer'20159,028,800'Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules'20158,932,593'Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses'20158,906,377'Stably tethered structures of defined compositions with multiple functions or binding specificities'20148,889,100'Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules'20148,877,202'Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer'20148,865,176'Methods and compositions for generating bioactive assemblies of increased complexity and uses'20148,829,175'Nucleic acids encoding polyvalent protein complexes'20148,808,665'In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents'20148,758,726'Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules'20148,709,382'Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules'20148,697,080'Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments'20148,652,484'Delivery system for cytotoxic drugs by bispecific antibody pretargeting'20148,632,752'In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents'20148,617,518'Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules'20138,545,809'Methods and compositions for improved 18F labeling of proteins, peptides and other molecules'20138,496,912'In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents'20138,444,956'Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules'20138,435,539'Delivery system for cytotoxic drugs by bispecific antibody pretargeting'20138,435,540'Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in VIVO'20138,398,956'In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents'20138,343,460'Methods and compositions for F-18 labeling of proteins, peptides and molecules'20138,333,971'Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments'20128,277,817'PEGylation by the dock and lock (DNL) technique'20128,246,960'Methods and compositions for generating bioactive assemblies of increased complexity and uses'20128,202,509'Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules'20128,188,239'Multivalent carriers of bi-specific antibodies'20128,163,291'Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses'20128,158,129'Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo'20128,158,573'Therapeutic and diagnostic conjugates for use with multispecific antibodies'20128,153,100'Methods and compositions for F-18 labeling of proteins, peptides and other molecules'20128,153,101'Methods and compositions for F-18 labeling of proteins, peptides and other molecules'20128,147,800'Methods and compositions for F-18 labeling of proteins, peptides and other molecules'20128,147,799'Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules'20128,097,252'Methods and compositions for administering therapeutic and diagnostic agents'20128,038,983'Fluorinated carbohydrate conjugates'20118,003,111'Dimeric alpha interferon pegylated site-specifically shows enhanced and prolonged efficacy in vivo'20117,993,626'Methods and compositions for F-18 labeling of proteins, peptides and other molecules'20117,981,398'PEGylation by the dock and lock (DNL) technique'20117,951,921'Multivalent carriers of bi-specific antibodies'20117,943,343'Production and use of novel peptide-based agents for use with bi-specific antibodies'20117,914,787'Production and use of novel peptide-based agents with bispecific antibodies'20117,906,121'Methods and compositions for generating bioactive assemblies of increased complexity and uses'20117,892,547'Methods and compositions for administering therapeutic and diagnostic agents'20117,871,622'Stably tethered structures of defined compositions with multiple functions or binding specificities'20117,842,279'F-18 peptides for pre targeted positron emission tomography imaging'20107,776,311'D-amino acid peptides'20107,666,415'Production and use of novel peptide-based agents for use with bi-specific antibodies'20107,666,400'PEGylation by the dock and lock (DNL) technique'20107,597,876'Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules'20097,563,433'Methods and compositions for F-18 labeling of proteins, peptides and other molecules'20097,563,439'Production and use of novel peptide-based agents for use with bi-specific antibodies'20097,560,110'Production and use of novel peptide-based agents with bispecific antibodies'20097,550,143'Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses'20097,534,431'Methods and compositions for administering therapeutic and diagnostic agents'20097,534,866'Methods and compositions for generating bioactive assemblies of increased complexity and uses'20097,521,056'Stably tethered structures of defined compositions with multiple functions or binding specificities'20097,521,416'D-amino acid peptides'20097,429,381'Production and use of novel peptide-based agents for use with bi-specific antibodies'20087,405,320'Therapeutic and diagnostic conjugates for use with multispecific antibodies'20087,172,751'D-amino acid peptides'20077,138,103'Use of bi-specific antibodies for pre-targeting diagnosis and therapy'20067,074,405'Use of bi-specific antibodies for pre-targeting diagnosis and therapy'20067,052,872'Bi-specific antibodies for pre-targeting diagnosis and therapy'20067,045,503'Radiometal-binding peptide analogues'20067,011,816'Labeling targeting agents with gallium-68 and gallium-67'20066,962,702'Production and use of novel peptide-based agents for use with bi-specific antibodies'20056,953,675'Landscaped antibodies and antibody fragments for clinical use'20056,576,746'Site-specific labeling of disulfide-containing targeting vectors'2003RE037710'Radiometal-binding analogues of luteinizing hormone releasing hormone'20026,126,916'Radiometal-binding peptide analogues'20006,071,490'Position emission tomography using gallium-68 chelates'20005,753,206'Radiometal-binding analogues of luteinizing hormone releasing hormone'19985,080,884'Hydrocarbylphenyl diaminodithiol radionuclide complexes and their use in imaging'19925,026,913'Hydrocarbylphenyl diaminodithiol derivatives'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–1992Based in Oakland, CA, US· patent location history
1998–2017Patents assigned to IMMUNOMEDICS INC (61)· patent assignee history
1998–2006Based in Summit, NJ, US· patent location history
2000Based in Simmit, NJ, US· patent location history
2006–2018Based in Boonton, NJ, US· patent location history
2009–2018Patents assigned to IBC PHARMACEUTICALS INC (22)· patent assignee history
2012–2016Patents assigned to MCBRIDE WILLIAM J (23)· patent assignee history
2012–2016Patents assigned to GOLDENBERG DAVID M (22)· patent assignee history
2012–2016Patents assigned to CHANG CHIEN-HSING (11)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNOMEDICS INC | 61 | 1998–2017 |
| MCBRIDE WILLIAM Jself | 23 | 2012–2016 |
| GOLDENBERG DAVID M | 22 | 2012–2016 |
| IBC PHARMACEUTICALS INC | 22 | 2009–2018 |
| CHANG CHIEN-HSING | 11 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Boonton, New Jersey, US | 73 | 2006–2018 |
| Summit, New Jersey, US | 9 | 1998–2006 |
| Oakland, California, US | 2 | 1991–1992 |
| Simmit, New Jersey, US | 1 | 2000 |